Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges
Since the reemergence of a severe acute respiratory syndrome caused by a novel coronavirus (SARS-CoV-2), the disease caused by this virus, known as COVID-19, has been spreading rapidly all around the world. As of early June 2020, COVID-19 has infected more that 6.6 million people, and has caused more than 390,000 deaths, globally. Similar to its pioneers, namely SARS-CoV and MERS-CoV, there is currently no vaccine or specific antiviral treatment against this virus. This review provides a timely overview on efforts as well as different platforms used for developing an effective vaccine against COVID-19..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Vaccine Research - 6(2019), 2, Seite 14-17 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pooneh Rhimi [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Themen: |
Covid-19 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ076256774 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ076256774 | ||
| 003 | DE-627 | ||
| 005 | 20230309142340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2019 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ076256774 | ||
| 035 | |a (DE-599)DOAJ1a1568e5a1df4aff8ca6e767e9ae1051 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Pooneh Rhimi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Since the reemergence of a severe acute respiratory syndrome caused by a novel coronavirus (SARS-CoV-2), the disease caused by this virus, known as COVID-19, has been spreading rapidly all around the world. As of early June 2020, COVID-19 has infected more that 6.6 million people, and has caused more than 390,000 deaths, globally. Similar to its pioneers, namely SARS-CoV and MERS-CoV, there is currently no vaccine or specific antiviral treatment against this virus. This review provides a timely overview on efforts as well as different platforms used for developing an effective vaccine against COVID-19. | ||
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a spike protein | |
| 650 | 4 | |a subunit vaccines | |
| 650 | 4 | |a covid-19 vaccines | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Science | |
| 653 | 0 | |a Q | |
| 700 | 0 | |a Mohammad Reza Aghasadeghi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Vaccine Research |d Pasteur Institute of Iran, 2020 |g 6(2019), 2, Seite 14-17 |w (DE-627)DOAJ078634237 |x 24234923 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2019 |g number:2 |g pages:14-17 |
| 856 | 4 | 0 | |u https://doaj.org/article/1a1568e5a1df4aff8ca6e767e9ae1051 |z kostenfrei |
| 856 | 4 | 0 | |u http://vacres.pasteur.ac.ir/article-1-194-en.html |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2383-2819 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2423-4923 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2019 |e 2 |h 14-17 | ||